Apnea Positive Pressure Long-Term Efficacy Study
The purpose of this study is to determine the effectiveness of nasal continuous positive airway pressure (CPAP) therapy for the treatment of obstructive sleep apnea syndrome (OSAS).
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- device: Active CPAP
- device: Sham CPAP
Eligibility
Inclusion Criteria:
- Male or female adults age 18 years or older with a diagnosis of OSAS using clinical
criteria defined by the study protocol
- Study participation may require seven or more laboratory visits over six months
Exclusion Criteria:
- Prior treatment for OSAS with continuous positive airway pressure or surgery
- Potential sleep apnea complications that may affect the health or safety of the
participant, including low blood oxygen, recent near-miss or prior automobile accident
due to sleepiness, congestive heart failure, history of angina, coronary artery
disease, myocardial infarction or stroke, cardiac rhythm disturbance, and chronic
neurological disorders affecting neurocognitive abilities or daily function
- The use of hypnotics, anxiolytics, sedating antidepressants, anticonvulsants, sedating
antihistamines, stimulants or other medications likely to affect neurocognitive
function and/or alertness
- Respiratory disease requiring medications (unless on stable medications for 2 months)
- Cancer, unless in remission for greater than one year and not taking exclusionary
medications
- Self-reported renal failure
- Pregnancy anytime during a subject's participation
- Psychiatric illness, as defined by a DSM-IV diagnosis, except for depression or mild
anxiety
- Narcolepsy, idiopathic hypersomnolence, DSM-IV chronic insomnia, restless legs
syndrome, or rapid eye movement (REM) behavior disorder
- Current use of diurnal or nocturnal supplemental oxygen
- Significant vision, hearing, or coordination problems
- Difficulty understanding or speaking English
- Currently working night or rotating shifts
- Consumption of more than 10 caffeinated beverages per day (approximately 1,000 mg per
day)
- Smokers whose habit interferes with the overnight polysomnogram or with the battery of
testing during the day
- Consumption of more than 2 alcoholic beverages per day
- Any illicit drug usage or marijuana usage more than once a week
- Any individual in the household currently on CPAP or on CPAP in the past
- A score of 26 or less on the Mini Mental State Examination (MMSE)
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Eileen Leary
6507249639
Not Recruiting
Our research team includes physicians, residents, medical students, research assistants, and volunteers. Our research topics include medical imaging, device validation, mobile application development, and pharmaceutical trials.
Some of the Neuro-Opthalmic concerns we investigate include Multiple Sclerosis, Optic Neuritis, IIH, and ICP.